Category: Diabetologia

Impact of pioglitazone on stroke outcomes: a real world database analysis

Post author By Morgan C L, Inzucchi S E, Jenkins-Jones S, Puelles J and Currie C J
Post date 7 May 2018

Morgan C L, Inzucchi S, Jenkins-Jones S, Puelles J, Currie C J. 07 May 2018

Rates of hospital admission for hypoglycaemia by glucose-lowering regimen and by glycated haemoglobin status in people with type 2 diabetes

Post author By Holden S E, Jenkins-Jones S and Currie C J
Post date 13 September 2016

Holden S E, Jenkins-Jones S, Currie C J. 13 Sep 2016

Survival as a function of HbA(1c) in people with type 2 diabetes using differing glucose-lowering regimens

Post author By Currie C J, Holden S E, Voss B, Rajpathak S N, Alemayehu B, Williams D, Berni E R, Jenkins-Jones S and Engel S S
Post date 13 September 2016

Currie C J, Holden S E, Voss B, Rajpathak S, Alemayehu B, Williams D, Berni E R, Jenkins-Jones S, Engel S S. 13 Sep 2016

Health service utilisation and costs of treatment with either exenatide twice daily or basal insulin for patients with type 2 diabetes: a retrospective UK study

Post author By Morgan C L, Jenkins-Jones S, Currie C J, Berni E R, Holden S E and Qiao Q
Post date 9 February 2016

Morgan C L, Jenkins-Jones S, Currie C J, Berni E R, Holden S E, Qiao Q. 09 Feb 2016

Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs

Post author By Holden S E, Bannister Ch A and Currie C J
Post date 3 June 2014

Holden S E, Bannister Ch A, Currie C J. 03 Jun 2014

Combination therapy with metformin plus sulfonylureas versus metformin plus DPP-4 inhibitors and risk of all-cause mortality

Post author By Currie C J, Jenkins-Jones S, Mukherjee J and Morgan C L
Post date 26 April 2014

Currie C J, Jenkins-Jones S, Mukherjee J, Morgan C L. 26 Apr 2014

Exogenous insulin and risk of all-cause mortality in type 2 diabetes: a dose-response association

Post author By Holden S E, Schernthaner G, Jenkins-Jones S and Currie C J
Post date 27 September 2013

Holden S E, Schernthaner G, Jenkins-Jones S, Currie C J. 27 Sep 2013

Association between first-line monotherapy with sulfonylurea versus metformin and risk of all-cause mortality

Post author By Jenkins-Jones S, Currie C J, Mukherjee J and Morgan C L
Post date 16 September 2013

Jenkins-Jones S, Currie C J, Mukherjee J, Morgan C L. 16 Sep 2013

ADVANCE and glycaemia thresholds: a need to clarify the statistical approach

Post author By Currie C J
Post date 18 May 2012

Currie C J. 18 May 2012

The longest ever randomised controlled trial of insulin glargine: study design and HbA1c findings

Post author By Currie C J
Post date 7 August 2009

Currie C J. 07 Aug 2009

Transforming real-world data into transparent, reliable, and reliable real-world evidence

44 (0) 2920 782856

enquiries@humandatasciences.com

24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone® is a Trusted Research Environment (TRE)

Quick Links

Quick Links

Transforming real-world data into transparent, reliable, and replicable real-world evidence

44 (0) 2920 782856

instantRWE@humandatasciences.com

The Global Pharma Research Centre,
24 Wordsworth Avenue, Cardiff, CF24 3FR United Kingdom

Copyright Pharmatelligence Limited (trading as Human Data Sciences) is a Private Limited Company (PLC) registered in England and Wales with Company Number 7107514.

Livingstone^® is a Trusted Research Environment (TRE)

Web Design – Create Summit

Copyright^© Human Data Sciences – All rights reserved

Site by Create Summit

Copyright © Human Data Sciences – All rights reserved